Taking a Patient-Centered, Multidisciplinary Team-Based Approach to Idiopathic Pulmonary Fibrosis in Clinical Practice
Jeffrey James Swigris, DO, MS
Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Marilyn K. Glassberg, MD
Professor of Medicine and
University of Miami Health System
This 3D, case-based, live activity will cover the diagnosis, treatment, and management of idiopathic pulmonary fibrosis (IPF) in clinical practice.
This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with IPF.
Upon completion of the program, attendees should be able to:
- Describe conditions to be considered in the differential diagnosis of IPF
- Assess the evidence base on recently approved pharmacotherapies for the treatment of IPF
- Discuss best practices for the provision of IPF patient-centered, multidisciplinary team-based management
ACCREDITATION AND DESIGNATION STATEMENTS
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
National Jewish Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number 12724, for 1.2 contact hours.
DISCLOSURE POLICY STATEMENT
As a sponsor accredited by the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health is dedicated to providing continuing medical education that is independent, fair, balanced, objective, and free of commercial bias. The Office of Professional Education and the Continuing Medical Education (CME) committee at National Jewish Health require that all scientific session faculty comply with all applicable laws and regulations governing disclosure. All financial interests or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services must be disclosed.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Dr. Jeffrey James Swigris reports that he has served as a consultant, investigator, and on advisory boards for Genentech and Boehringer Ingelheim. He has received grants and honoraria from Genentech and Boehringer Ingelheim for these services.
Dr. Marilyn Glassberg reports that she has served on advisory boards for Genentech and Boehringer Ingelheim. In addition, she has served as a consultant for Genentech, Boehringer Ingelheim, Bellerophon, and has other financial affiliations with Genentech and Boehringer Ingelheim. She has also served as an Investigator for Genentech.
The independent reviewers, staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests:
CME Content Review
This activity was reviewed by Dr. Amen Sergew, she has nothing to disclose.
CNE Content Review
This activity was reviewed by Allidah Hicks, RN, she has nothing to disclose.
Staff, planners, and managers
Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
Brooke Hefele, Outcomes Coordinator for Med Learning Group, has nothing to disclose.
Nina Oshiokpekha, Medical Director, Scientific and Medical Services for Med Learning Group, has nothing to disclose.
Sharine Griggs, Program Manager for Med Learning Group, has nothing to disclose.
Andrea Harshman, MHA, CHCP, CMP-HC, Director, Office of Professional Education for National Jewish Health, has nothing to disclose.
Stephanie Corder, ND, RN, CHCP, Accreditation and Programs Manager of Professional Education for National Jewish Health, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
National Jewish Health and Med Learning Group require that faculty participating in any CME/CNE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures;
2. Participate in the enduring activity; and
3. Complete pre-and-post surveys and evaluation.
You will receive your certificate as a downloadable file.
For CME questions, please contact Med Learning Group at firstname.lastname@example.org
For questions about the CME or CNE certification of this activity, please contact the Office of Professional Education at National Jewish Health at email@example.com
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course, or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at firstname.lastname@example.org
RELEASE DATE: December 12, 2018
EXPIRATION DATE: December 12, 2019
Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.